Most Recent
Biotech giant CSL has lost its challenge to a Fair Work Commission decision that found it unfairly sacked one of its workers deemed too sick to carry on with his duties.
The Fair Work Commission has thrown out an unfair dismissal case by a Sydney-based hospital employee who was fired after an unsolicited and "highly offensive" Instagram message to a young nurse.
The Australian Competition and Consumer Commission is seeking special leave from the High Court to appeal a ruling in a case alleging drug giant Pfizer misused its market power ahead of the expiration of its patent for Lipitor.
A Federal Court judge has dismissed proceedings by US pharma giant Geneva Laboratories against disgraced Sydney pharmacist Mina Attia over sales of 1,000 counterfeit Bio-Oil skincare bottles, calling it "madness" and a misuse of the court.
Danone's Nutricia unit has defeated a challenge by New Zealand's dairy cooperative Fonterra to registration of an Australian patent for the use of a nutritional pill for increasing weight gain in frail, elderly people.
A judge overseeing a securities class action against former directors of failed pharmaceutical company QRxPharma and its legal advisor DibbsBarker has ruled that certain documents, including numerous emails sent by the law firm, are protected by attorney-client privilege.
The corporate regulator has launched civil proceedings against the former managing director of sandalwood oil producer Quintis, after the company kept its board in the dark about the termination of a supply contract with Nestle unit Galderma.
Generic pharmaceutical company Aspen Pharma has resolved a patent infringement case brought by the maker of the anti-depressant Lexapro, according to a Federal Court order Tuesday.
A judge has granted F. Hoffman La-Roche's request for a temporary order blocking Sandoz from making or selling a biosimilar version of its patented biologic used to treat various cancers and rheumatoid arthritis.
GlaxoSmithKline is pushing for lower penalties in a case brought by the Australian Competition and Consumer Commission alleging the pharma giant breached the Australian Consumer Law in the marketing for its Voltaren Osteo Gel and Voltaren Emulgel pain relief products.